| LLY |
Eli Lilly and Company |
710.10B |
22.12% |
|
|
|
|
|
748.01 |
-0.25% |
37.76% |
41.27% |
|---|
| JNJ |
Johnson & Johnson |
373.59B |
21.90% |
|
|
|
|
|
155.17 |
-0.21% |
17.37% |
26.62% |
|---|
| BMY |
Bristol-Myers Squibb Company |
119.40B |
4.87% |
|
|
|
|
|
58.87 |
1.10% |
22.74% |
15.10% |
|---|
| VTRS |
Viatris Inc. |
15.96B |
4.67% |
|
|
|
|
|
13.37 |
1.83% |
24.36% |
5.83% |
|---|
| PFE |
Pfizer Inc. |
145.36B |
4.33% |
|
|
|
|
|
25.65 |
2.07% |
29.45% |
63.08% |
|---|
| ZTS |
Zoetis Inc. |
79.84B |
4.30% |
|
|
|
|
|
176.96 |
0.14% |
22.02% |
6.12% |
|---|
| CTLT |
Catalent, Inc. |
11.07B |
4.17% |
|
|
|
|
|
60.98 |
2.21% |
28.53% |
25.41% |
|---|
| RPRX |
Royalty Pharma plc |
11.74B |
4.13% |
|
|
|
|
|
26.43 |
0.11% |
61.51% |
41.52% |
|---|
| MRK |
Merck & Co., Inc. |
250.89B |
4.08% |
|
|
|
|
|
99.18 |
-0.68% |
22.82% |
38.87% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
9.08B |
2.96% |
|
|
|
|
|
85.69 |
0.28% |
26.13% |
4.60% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.66B |
2.71% |
|
|
|
|
|
126.67 |
1.25% |
43.88% |
39.21% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
6.60B |
2.43% |
|
|
|
|
|
13.36 |
-0.30% |
39.46% |
25.31% |
|---|
| OGN |
Organon & Co. |
3.94B |
1.80% |
|
|
|
|
|
15.28 |
2.62% |
45.94% |
50.52% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
6.03B |
1.76% |
|
|
|
|
|
57.54 |
2.90% |
64.47% |
30.74% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.78B |
1.43% |
|
|
|
|
|
98.68 |
0.50% |
78.74% |
74.83% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
4.19B |
1.43% |
|
|
|
|
|
84.85 |
0.84% |
32.58% |
29.08% |
|---|
| PRGO |
Perrigo Company plc |
3.83B |
1.41% |
|
|
|
|
|
28.07 |
3.66% |
41.02% |
37.00% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
2.25B |
0.83% |
|
|
|
|
|
119.19 |
2.27% |
46.75% |
37.63% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
3.05B |
0.79% |
|
|
|
|
|
32.20 |
0.69% |
108.62% |
27.38% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
2.19B |
0.76% |
|
|
|
|
|
45.46 |
2.04% |
82.32% |
49.30% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
2.00B |
0.74% |
|
|
|
|
|
36.22 |
1.12% |
42.93% |
42.60% |
|---|
| ARVN |
Arvinas, Inc. |
1.78B |
0.69% |
|
|
|
|
|
25.86 |
2.99% |
89.66% |
43.56% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
1.84B |
0.60% |
|
|
|
|
|
48.24 |
3.97% |
114.60% |
50.56% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.88B |
0.50% |
|
|
|
|
|
8.39 |
0.84% |
78.22% |
46.05% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
1.94B |
0.49% |
|
|
|
|
|
34.07 |
2.53% |
66.52% |
52.29% |
|---|
| SAVA |
Cassava Sciences, Inc. |
1.27B |
0.47% |
|
|
|
|
|
26.48 |
-17.71% |
435.84% |
95.72% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
966.22M |
0.45% |
|
|
|
|
|
29.96 |
-1.48% |
126.46% |
63.20% |
|---|
| INVA |
Innoviva, Inc. |
1.20B |
0.43% |
|
|
|
|
|
19.15 |
0.47% |
46.99% |
35.57% |
|---|
| ANIP |
ANI Pharmaceuticals, Inc. |
1.20B |
0.38% |
|
|
|
|
|
56.91 |
1.88% |
44.91% |
40.45% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
1.56B |
0.38% |
|
|
|
|
|
9.74 |
0.52% |
178.61% |
53.78% |
|---|
| ELVN |
Enliven Therapeutics, Inc. |
1.20B |
0.33% |
|
|
|
|
|
24.54 |
-3.42% |
97.95% |
18.22% |
|---|
| PCRX |
Pacira BioSciences, Inc. |
810.34M |
0.31% |
|
|
|
|
|
17.55 |
0.98% |
55.56% |
17.24% |
|---|
| PLRX |
Pliant Therapeutics, Inc. |
789.88M |
0.31% |
|
|
|
|
|
12.98 |
1.01% |
108.82% |
31.24% |
|---|
| PHAT |
Phathom Pharmaceuticals, Inc. |
638.64M |
0.24% |
|
|
|
|
|
9.34 |
-1.16% |
98.66% |
19.61% |
|---|
| RVNC |
Revance Therapeutics, Inc. |
391.28M |
0.21% |
|
|
|
|
|
3.73 |
-2.86% |
331.30% |
60.78% |
|---|
| MMED.NE |
MIND MEDICINE SUBORDINATE VOTING I |
|
0.19% |
|
|
|
|
|
|
|
|
|
|---|
| NUVB |
Nuvation Bio Inc. |
942.39M |
0.16% |
|
|
|
|
|
2.8000 |
3.70% |
168.21% |
20.25% |
|---|
| TBPH |
Theravance Biopharma, Inc. |
465.68M |
0.12% |
|
|
|
|
|
9.47 |
-1.46% |
38.81% |
29.42% |
|---|
| XTSLA |
BLK CSH FND TREASURY SL AGENCY |
|
0.10% |
|
|
|
|
|
|
|
|
|
|---|
| SGAFT |
CASH COLLATERAL USD SGAFT |
|
0.01% |
|
|
|
|
|
|
|
|
|
|---|
| IXCZ4 |
E-MINI HEALTH CARE SECTOR DEC 24 |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|